| (Values in U.S. Thousands) | Sep, 2024 | Jun, 2024 | Mar, 2024 | Dec, 2023 | Sep, 2023 |
| Sales | 6,410 | 5,580 | 6,710 | 2,970 | 11,240 |
| Sales Growth | +14.87% | -16.84% | +125.93% | -73.58% | +198.94% |
| Net Income | -67,800 | -45,740 | -26,640 | -51,280 | -39,510 |
| Net Income Growth | -48.23% | -71.70% | +48.05% | -29.79% | +12.28% |
Exscientia Ltd ADR
(EXAI)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Exscientia plc is an AI-driven pharmatech company. It involved in discovering, designing and developing drugs. Exscientia plc is based in OXFORD, England.
Fiscal Year End Date: 12/31